Background Systemic glucocorticoids reduce the incidence of bronchopulmonary dysplasia
among extremely preterm infants, but they may compromise brain development. The effects …

Importance A single course of antenatal corticosteroid therapy is recommended for pregnant
women at risk of preterm birth between 24 and 33 weeks' gestational age. However, 50% of …

Objective To assess the impact of antenatal corticosteroids (ACS) on neonatal mortality,
cerebral lesions and 5‐year neurodevelopmental outcome of infants born at 24–27 and 28 …

Background: Dexamethasone treatment started soon after birth is controversial. Objectives:
To determine if postnatal dexamethasone treatment during the first week of life is beneficial …

Background: Postnatal corticosteroid therapy has been proved in randomized controlled
trials to reduce ventilator dependence and the rate of chronic lung disease in preterm infants …

Background The long-term effects on neurodevelopment of the use of inhaled
glucocorticoids in extremely preterm infants for the prevention or treatment of …

Background Postnatal corticosteroids (PNC) were widely used to treat and prevent
bronchopulmonary dysplasia in preterm infants until studies showed increased risk of …

Bronchopulmonary dysplasia (BPD) is a chronic lung disease commonly affecting extremely
preterm infants. Although mechanical ventilation and oxygen requirements in premature …

Background This is an update of a review published in 2012. A related review" Inhaled
versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated …

OBJECTIVE: The aim of this study was to determine the effects of repeated courses of
prenatal corticosteroid therapy versus placebo on death or neurologic impairment among …